CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

March 16, 2023 · earnings

GLUE earnings: a positive outcome, +7.4%

On March 16, 2023, Monte Rosa Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +7.4% in the window around the event. It had already run -12.5% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$6.53
1d before
$7.01
Event day
$7.22
1d after
$6.78
5d after

Pre-catalyst setup

-12.5%
30-day run-up
5766%
30-day volatility
0.6×
volume spike